Sign in

or Register now

MyRACentral.com

See all of our health sites at www.HealthCentral.com
Friday, July, 25, 2008

Christine Miller's SharePosts Relating to: "Alert"

FDA Advisory Panel to Evaluate Arcoxia - Vioxx Replacement

On Thursday, April 12 an FDA advisory panel will discuss whether or not to recommend that the FDA approve Merck & Co’s COX-2 inhibitor, Arcoxia (etoricoxib).  The drug is manufactured by Merck, the same company that made Vioxx, which was pulled from the market in the fall of 2004.  Merck applied for approval to sell Arcoxia... Read moreChevron

Add comment  |  No Comments

Merck Loses Another Vioxx Lawsuit

   Health and finance media outlets are abuzz this week after a jury in New Jersey found that in the case of a Mr. Humeston of Idaho, Merck was intentionally and recklessly negligent in failing to provide adequate warning of the risks of taking Vioxx in the drug's package inserts.  The jury also found that Vioxx contributed... Read moreChevron

Another Advance in Genetic Research

Scientists studying genetic links to autoimmune disorders have made the news again this week with research linking 30 genes to autoimmune disorders such as rheumatoid arthritis, lupus and others. Newsweek published an interview this week online with two of the researchers from MIT’s Whitehead Institute.   The scientists hope that the... Read moreChevron

Add comment  |  No Comments

Individualization and Follow-up are Key to Successful Exercise Pr

A recent article in the online December issue of Arthritis & Rheumatism compared the effectiveness of two different types of Internet-based physical activity interventions for people with rheumatoid arthritis. In this study from the Netherlands, 160 patients were monitored over a period of a year. The patients were divided into two groups... Read moreChevron

Add comment  |  No Comments

Vioxx Heart Attack Risk Linked to Blood Clotting

A recent study may provide hope that scientists will one day be able to develop COX-2 inhibitor drugs, such as Celebrex and Vioxx, that do not have the associated risk of heart attacks and strokes. The research, published in the December issue of the Federation of American Societies for Experimental Biology (FASEB), found that Vioxx and the... Read moreChevron

Add comment  |  No Comments

Ask a Question

Get answers from our experts and community members.

Answer a Question

arthritis and coumadin

Answer This View all questions >
Healthcare 08